127969-90-8

Basic information

• Product Name: 2,6-Octadien-1-ol, 8-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-3,7-dimethyl-, (2E,6E)-
• CAS NO: 127969-90-8
• Molecular Formula: C26H36O2Si
• Molecular Weight: 408.656
• Mol File: 127969-90-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2,6-Octadien-1-ol, 8-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-3,7-dimethyl-, (2E,6E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-Octadien-1-ol, 8-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-3,7-dimethyl-, (2E,6E)-(127969-90-8)
• EPA Substance Registry System: 2,6-Octadien-1-ol, 8-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-3,7-dimethyl-, (2E,6E)-(127969-90-8)

Safety Data

• Hazardous Substances Data: 127969-90-8(Hazardous Substances Data)

Upstream product

• 105-87-3 3,7-dimethyl-2E,6-octadien-1-yl acetate 
• 37905-03-6 8-hydroxygeranyl acetate 
• 947691-09-0 (2E,6E)-8-((tert-butyldiphenylsilyl)oxy)-3,7-dimethylocta-2,6-dien-1-yl acetate 

Downstream Products

• 1523187-45-2 C₃₆H₄₄O₇Si 
• 1523187-51-0 C₃₆H₄₂O₆Si 
• 1523187-39-4 C₃₈H₄₈O₇Si 
• 553-21-9 costunolide 
• 1028386-60-8 (6E)-8-(tert-butyldiphenylsilyloxy)geranyl chloride 
• 844868-79-7 7-{2-[4-(8-hydroxy-3,7-dimethylocta-6,7-dienyl)-3,5-bis(methoxymethoxy)phenyl]vinyl}-5-methoxy-1,1,4a-trimethyl-2,3,4,4a,9,9a-hexahydro-1H-xanthen-2-ol 
• 865761-93-9 {4-[8-(tert-butyldiphenylsilanyloxy)-3,7-dimethylocta-2,6-dienyl]-3,5-bis(methoxymethoxy)benzyl}phosphonic acid diethyl ester 
• 865761-92-8 tert-butyl-{8-[4-iodomethyl-2,6-bis(methoxymethoxy)phenyl]-2,6-dimethylocta-2,6-dienyloxy}diphenylsilane 
• 865761-91-7 {4-[8-(tert-butyldiphenylsilanyloxy)-3,7-dimethylocta-2,6-dienyl]-3,5-bis(methoxymethoxy)phenyl}methanol 
• 865761-69-9 [4-(8-hydroxy-3,7-dimethylocta-2,6-dienyl)-3,5-bis(methoxymethoxy)benzyl]phosphonic acid diethyl ester 

Relevant articles and documents

Synthesis of a series of promising isobenzofuranones for the treatment of acute mucositis caused by chemo- and radiotherapy

A small series of 3,5-dihydroxy-7-methoxy-3,6-dimethylshyisobenzofuran- 1(3H)-one analogues of the immunosuppressant, mycophenolate mofelite (MMF), has been identified during a screening campaign as possible mediators to prevent mucositis. Herein, we pres

CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND

The present invention relates to a cyclisation process of forming a multiple ring compound from an isoprenoid compound. The cyclisation process involves reacting the isoprenoid compound with an acetal initiator under conditions sufficient to form the multiple ring compound. The isoprenoid compound is contacted with an initiator an optionally with a catalyst. Cyclisation occurs by reaction of the initiator with the isoprenoid compound. Cyclic aceta compounds wherein the acetal forms part of 6-membered unsaturated ring are also defined.